.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Teva
Dow
QuintilesIMS
Chinese Patent Office
Cipla
Argus Health
Cerilliant
UBS

Generated: December 12, 2017

DrugPatentWatch Database Preview

Mutual Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for MUTUAL PHARM, and what generic and branded alternatives to MUTUAL PHARM drugs are available?

MUTUAL PHARM has fifty-nine approved drugs.



Summary for Mutual Pharm

US Patents:0
Tradenames:26
Ingredients:25
NDAs:59
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mutual PharmPROPOXYPHENE NAPSYLATE AND ACETAMINOPHENacetaminophen; propoxyphene napsylateTABLET;ORAL070615-001Mar 21, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mutual PharmINDOMETHACINindomethacinCAPSULE;ORAL070068-001Oct 3, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mutual PharmCHLORTHALIDONEchlorthalidoneTABLET;ORAL089738-001Sep 19, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mutual PharmPREDNISONEprednisoneTABLET;ORAL089245-001Dec 4, 1985ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mutual PharmSPIRONOLACTONE AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; spironolactoneTABLET;ORAL087267-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mutual PharmHYDROCODONE BITARTRATE AND ACETAMINOPHENacetaminophen; hydrocodone bitartrateTABLET;ORAL040236-002Sep 25, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mutual PharmDOXYCYCLINE HYCLATEdoxycycline hyclateCAPSULE;ORAL062418-001Jan 28, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mutual PharmMINOXIDILminoxidilTABLET;ORAL072708-001Dec 14, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mutual PharmHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL088728-001Apr 11, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mutual PharmPREDNISONEprednisoneTABLET;ORAL084634-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Accenture
Novartis
Boehringer Ingelheim
Harvard Business School
Chubb
Colorcon
Cantor Fitzgerald
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot